T. Rowe Price Associates
SLN

T. Rowe Price Associates’s Silence Therapeutics SLN Stock Holding History

T. Rowe Price Associates’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-228,644
Closed -$4.16M – 3046
2024
Q3 		$4.16M Buy
+228,644
New +$4.16M ﹤0.01% 1352